Eli Berlin ^UDM

Eli Berlin, the Co-Founder of Terray Therapeutics, spearheads a biotechnology company committed to transforming the small molecule therapeutics landscape. Terray integrates ultra-high throughput experimentation with generative AI, biology, and nanotechnology to explore molecules and targets comprehensively. Eli's leadership is crucial in driving the company's iterative approach, which generates vast amounts of precise data, increasingly valuable in each cycle of design and experimentation, to improve the success rate of drug discovery and development.